The Health & Pharma Supply Chain Summit will dive into the networks that keep us safe and healthy. With COVID-19 vaccine distribution expected to be fully underway in the U.S. by February 2021, there will be many lessons learned and analysis to be discussed. In addition, the complex world of pharmaceutical supply chains, regardless of a pandemic, involves numerous stakeholders and risks. In a sector not typically recognized for its agility, how can healthcare supply chains remain safe and adapt to new technologies?
Click On Each Session For More Information; All times shown in EST.
Tracking and visibility of prodcusts on the move is important for all industries, but maybe none more so then pharmaceuticals and healthcare. The delicate nature of pharmaceuticals and healthcare equipment combined with its high value makes it a vital ingredient in the supply chain.
Todd Fagley, the CEO and co-founder of MedSource Labs, spoke with John Kingston to discuss the supply chain challenges that the medical supply sector has faced in the age of the pandemic. MedSource is a manufacturer and distributor of a wide range of medical supplies. For one thing, there’s a lot more air freight than there was before. And like most companies in the medical supply chain, MedSource has needed to step up taking care of immediate pressing demands from customers and had to put some long-range development on hold. But they’re getting back to that now.
XPO has been distributing protective personal equipment since the start of the pandemic. This experience laid the foundation for the speed and agility it takes for aligning its vast delivery network to the needs of distributing the Covid-19 vaccine.
Wolfgang Lehmacher, a former supply chain expert at the World Economic Forum, stops by to provide insights on recent progress in vaccine delivery, the technology needed to maximize the impact of this vaccine and predict how long before it spoils, and the potential this holds for the future.
Scott Sangster, Vice President of Global Sales at Descartes Systems Group sat down with FreightWaves' Andrew Cox to discuss the challenges of pharmaceutical transportation. Scott details the pain points of the current system, the advantages of leveraging mesh networks and BLE tags, and what the logistics community needs to do to achieve end-to-end visibility for all parties.
Covid-19 has distrupted trade patterns and relations in every industry. For the pharmaceutical industry disruptions are even more serious as a large percentage of PPE and medicines are sourced from China.
Each region presents a different challenge in creating efficient medical supply chains to address the unique needs of its populations. Nowhere is that more evident than in the rollout of the COVID-19 vaccine. PowerFleet CEO Chris Wolfe dives into the different technologies and approaches to getting critical medical supplies around the globe from Israel to Africa.
Join Susanne Somerville, CEO of Chronicled, the custodian of MediLedger, and Patrick Duffy, the President of Blockchain in Transport Alliance (BiTA) as they discuss the state of enterprise blockchain, how this technology has evolved over the past few years, and what opportunities (and. Challenges) are on the horizon coming out of the pandemic.
Amid the unforeseen effects of the pandemic on at-risk and lower-income communities, governments and organizations around the world must convene to ensure effective distribution of newly developed vaccines.
Vaccine demand planning requires coordination across the supply chain spectrum. Logistics, materials management, and operations need to support clinicians at the point of care to maximize community protection. Come hear a lively healthcare supply chain conversation between John Ervin and Andrew Kelley who will cover demand planning, healthcare operations, metrics, constraints and what you need to know.